Chronic kidney disease and its complications:
ALBUMINURIA
Albuminuria is an important prognostic feature in chronic kidney disease. The degree of albuminuria relates to the severity of the kidney disease and with a greater likelihood of progression to end stages of chronic kidney disease. The amount of albuminuria can be reduced significantly by the use of an ACE inhibitor (Angiotensin-converting enzyme inhibitor) and ARB (Angiotensin II receptor blocker) agent. Reduction in the amount of albuminuria is associated with improved outcomes
Management
- ACE inhibitor or ARB therapy as first-line therapy
- Reduction in salt output through reducing oral salt intake
- Spironolactone (use with caution on specialist advice and ensure regular monitoring of serum potassium)
No comments:
Post a Comment